Active Ingredient: Cabergoline 0.25/0.5 mg
Indications: Hyperprolactinemia, galactorrhea, infertility associated with prolactin imbalance.
Dosage: 0.5 mg/week to start, maintenance dose 0.25-2 mg/week.
Key Benefits
Prolactin Normalization: Reduces elevated prolactin levels, thus restoring normal menstrual cycles and fertility.
Ovulation Induction: For women experiencing anovulation due to high prolactin levels, Embi-Cab helps restore a regular ovulatory cycle, significantly enhancing the chances of conception.
Safe for Long-term Use: The low side-effect profile of cabergoline (compared to other medications like bromocriptine) makes it ideal for long-term management in hyperprolactinemia.
Advantages:
Proven to normalize prolactin levels and restore menstrual cycles in women with hyperprolactinemia.
Low incidence of side effects compared to other prolactin inhibitors (e.g., Bromocriptine).
Benefits:
Restores gonadal function and promotes ovulatory cycles.
Improves fertility by reducing elevated prolactin levels, which can suppress ovulation.
Effective in managing hyperprolactinemia, galactorrhoea, and related infertility.
Assists in regulating menstrual cycles in women with irregular periods due to high prolactin.
Description
